Journal article
Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) has been identified as the aetiological agent of SARS. Thus, vaccination against SARS-CoV may represent an effective approach towards controlling SARS. The nucleocapsid (N) protein is thought to play a role in induction of cell-mediated immunity to SARS-CoV and thus it is important to characterize this protein. In the present study, an E1/partially E3-deleted, replication-defective human …
Authors
Zakhartchouk AN; Viswanathan S; Mahony JB; Gauldie J; Babiuk LA
Journal
Journal of General Virology, Vol. 86, No. 1, pp. 211–215
Publisher
Microbiology Society
Publication Date
January 1, 2005
DOI
10.1099/vir.0.80530-0
ISSN
0022-1317
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdenoviridaeAnimalsAntibodies, ViralDrug Evaluation, PreclinicalFemaleGenetic VectorsMiceMice, Inbred C57BLMolecular WeightNucleocapsid ProteinsPhosphorylationRecombinant ProteinsSevere acute respiratory syndrome-related coronavirusSevere Acute Respiratory SyndromeT-LymphocytesVaccinationViral Vaccines